{
    "2021-09-02": [
        [
            {
                "time": "2023-10-01",
                "original_text": "恒瑞医药获得药品注册证书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "药品注册证书",
                        "罂粟乙碘油注射液"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "医药行业21年中报综述：费用调整、研发为重，结构分化、上游占优",
                "features": {
                    "keywords": [
                        "医药行业",
                        "中报",
                        "费用调整",
                        "研发",
                        "结构分化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "恒瑞医药(600276.SH)获“罂粟乙碘油注射液”药品注册证书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "罂粟乙碘油注射液",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "恒瑞医药：碘佛醇注射液通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "碘佛醇注射液",
                        "仿制药一致性评价"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "北向资金9天加仓近390亿，紫金矿业大幅净买入超11亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "紫金矿业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "矿业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "恒瑞医药：公司目前正在积极推进新官网的搭建，近期将正式上线",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "新官网",
                        "搭建"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "创新药贡献四成营收 恒瑞医药再加码肿瘤赛道",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "创新药",
                        "肿瘤赛道"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "恒瑞医药拟用于帕金森病治疗药物获批临床",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "帕金森病",
                        "治疗药物",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "A股融资融券日报：两融余额增加19.57亿元（9月1日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "A股97家创新药企业上半年研发投入逾180亿元",
                "features": {
                    "keywords": [
                        "A股",
                        "创新药",
                        "研发投入"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}